Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations

Clinical Phenotype Classification of Atrial Fibrillation Patients Using Cluster Analysis and Associations with Trial-Adjudicated Outcomes

(2021) Marco Vitolo et al.   Biomedicines

Procedural complications in patients undergoing catheter ablation for atrial fibrillation: let's talk about sex

(2021) Jacopo Francesco Imberti et al.   European Heart Journal-Quality of Care and Clinical Outcomes

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

(2021) Marco Proietti et al.   BMC Medicine

Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis

(2021) Xinxing Gao et al.   Frontiers in Cardiovascular Medicine

The Tasmanian Atrial Fibrillation Study (TAFS): Differences in Stroke Prevention According to Sex

(2020) Sophie M. Pilcher et al.   ANNALS OF PHARMACOTHERAPY

Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

(2020) Yutao Guo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Female Sex as a Risk Modifier for Stroke Risk in Atrial Fibrillation: Using CHA2DS2-VASc versus CHA2DS2-VA for Stroke Risk Stratification in Atrial Fibrillation: A Note of Caution

(2020) Peter Brønnum Nielsen et al.   THROMBOSIS AND HAEMOSTASIS

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

(2020) Jason G. Andrade et al.   CANADIAN JOURNAL OF CARDIOLOGY

Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

(2020) Marco Proietti et al.   EUROPACE

Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort

(2020) Yutao Guo et al.   European Journal of Internal Medicine

The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation

(2020) Tatjana S. Potpara et al.   THROMBOSIS AND HAEMOSTASIS

Women and atrial fibrillation

(2020) Annabelle Santos Volgman et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation

(2019) Tze-Fan Chao et al.   ANNALS OF INTERNAL MEDICINE

Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48

(2019) David Douglas Berg et al.   CIRCULATION

Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study

(2019) Hyunjean Jung et al.   THROMBOSIS AND HAEMOSTASIS

Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially ‘Low-Risk’ Patients

(2019) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

Stroke Prevention, Evaluation of Bleeding Risk and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines

(2019) Marco Proietti et al.   CANADIAN JOURNAL OF CARDIOLOGY

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)

(2019) Miklos Rohla et al.   BMJ Open

External Validation of the ORBIT Bleeding Score and the HAS-BLED Score in Nonvalvular Atrial Fibrillation Patients Using Direct Oral Anticoagulants (Asian Data from the DIRECT Registry)

(2019) Naoki Mori et al.   AMERICAN JOURNAL OF CARDIOLOGY

Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores

(2019) José Miguel Rivera-Caravaca et al.   STROKE

Improved Population-Based Clinical Outcomes of Patients with Atrial Fibrillation by Compliance with the Simple ABC (Atrial Fibrillation Better Care) Pathway for Integrated Care Management: A Nationwide Cohort Study

(2019) Minjae Yoon et al.   THROMBOSIS AND HAEMOSTASIS

Female sex and stroke in atrial fibrillation: an intriguing relationship

(2019) Giuseppe Boriani et al.   Internal and Emergency Medicine

Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation

(2018) Yutao Guo et al.   AMERICAN JOURNAL OF MEDICINE

Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation

(2018) Peter Brønnum Nielsen et al.   CIRCULATION

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference

(2018) Dipak Kotecha et al.   EUROPACE

Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients

(2018) Irene Marzona et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study

(2018) Tze-Fan Chao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors

(2018) Tze-Fan Chao et al.   THROMBOSIS AND HAEMOSTASIS

Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study

(2018) Minjae Yoon et al.   THROMBOSIS AND HAEMOSTASIS

Stroke Risk Stratification for Atrial Fibrillation Patients With Hypertrophic Cardiomyopathy

(2018) Hyunjean Jung et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review

(2018) Ethan Borre et al.   THROMBOSIS AND HAEMOSTASIS

Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients

(2018) Marco Proietti et al.   European Journal of Preventive Cardiology

Female gender as a risk factor for stroke associated with atrial fibrillation

(2017) A. John Camm et al.   EUROPEAN HEART JOURNAL

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial

(2017) M. Proietti et al.   JOURNAL OF INTERNAL MEDICINE

The future of atrial fibrillation management: integrated care and stratified therapy

(2017) Paulus Kirchhof   LANCET

The ABC pathway: an integrated approach to improve AF management

(2017) Gregory Y. H. Lip   Nature Reviews Cardiology

Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences

(2017) Marco Proietti et al.   PHARMACOLOGICAL RESEARCH

Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation

(2017) Nina A. Hilkens et al.   STROKE

CHA 2 DS 2 -VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke

(2017) Tae-Hoon Kim et al.   STROKE

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

(2017) María Esteve-Pastor et al.   THROMBOSIS AND HAEMOSTASIS

Comparing the ORBIT and HAS-BLED bleeding risk scores in anticoagulated atrial fibrillation patients: a systematic review and meta-analysis

(2017) Cen Wang et al.   Oncotarget

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

(2017) Keith A A Fox et al.   BMJ Open

Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor

(2016) Laurent Fauchier et al.   CHEST

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial FibrillationClinical Perspective

(2016) Jonas Oldgren et al.   CIRCULATION

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

(2016) María Asunción Esteve-Pastor et al.   CIRCULATION JOURNAL

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

(2016) Ziad Hijazi et al.   EUROPEAN HEART JOURNAL

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

(2016) Ziad Hijazi et al.   LANCET

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

(2016) Sean D. Pokorney et al.   Journal of the American Heart Association

Validation of CHA2DS2-VASc and HAS-BLED Scores in Japanese Patients With Nonvalvular Atrial Fibrillation

(2014) Ken Okumura et al.   CIRCULATION JOURNAL

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation

(2013) G. Ntaios et al.   NEUROLOGY

A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk Score

(2013) Daniel E. Singer et al.   Journal of the American Heart Association

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation

(2012) J. M. L. Hendriks et al.   EUROPEAN HEART JOURNAL

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage

(2011) Margaret C. Fang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST